PAVmed (PAVM) Amortization - Intangibles (2021 - 2024)
PAVmed's (PAVM) quarterly Amortization - Intangibles came in at $105000.0 in Q2 2024, down 79.21% year-on-year from $505000.0 in Q3 2023, and down 71.77% quarter-over-quarter from $372000.0 in Q1 2024.
PAVmed (PAVM) Amortization - Intangibles (2021 - 2024) Analysis & Trends
PAVmed's Amortization - Intangibles history runs 4 years deep, the most recent figure standing at $105000.0 for Q2 2024.
- On a quarterly basis, Amortization - Intangibles fell 79.21% year-over-year to $105000.0 in Q2 2024; TTM through Dec 2024 was $982000.0, a 51.39% decrease from a year earlier, with the FY2024 full-year figure at $559000.0, down 72.34% from the prior year.
- Amortization - Intangibles eased to $105000.0 in Q2 2024 per PAVM's latest filing, from $372000.0 in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $650000.0 in Q2 2022 and bottomed at $17000.0 in Q3 2021.
- The 4-year median for Amortization - Intangibles is $505000.0 (2022), against an average of $368416.7.
- Across the five-year window, Amortization - Intangibles jumped 2870.59% in 2022 and tumbled 79.21% in 2024, its largest moves.
- Year by year, Amortization - Intangibles stood at $123000.0 in 2021, then surged by 311.38% to $506000.0 in 2022, then dropped by 0.2% to $505000.0 in 2023, then tumbled by 79.21% to $105000.0 in 2024.
- Per Business Quant, the three latest PAVM Amortization - Intangibles figures stand at $105000.0 (Q2 2024), $372000.0 (Q1 2024), and $505000.0 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | PAVmed | 9.85 Mn | -3.35 Mn | -4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 372,000.00 |
| Dec 31, 2023 | 505,000.00 |
| Sep 30, 2023 | 505,000.00 |
| Jun 30, 2023 | 505,000.00 |
| Mar 31, 2023 | 505,000.00 |
| Dec 31, 2022 | 506,000.00 |
| Sep 30, 2022 | 505,000.00 |
| Jun 30, 2022 | 650,000.00 |
| Mar 31, 2022 | 123,000.00 |
| Dec 31, 2021 | 123,000.00 |
| Sep 30, 2021 | 17,000.00 |